Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
vonoprazan + amoxicillin + clarithromycin
- Development stage
- Approved
- Lead developer
- Phathom Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Vonoprazan + amoxicillin + clarithromycin is a co-packaged medication used for the treatment of Helicobacter pylori (H. pylori) infection in adults. This combination therapy consists of vonoprazan, a potassium-competitive acid blocker (PCAB) that decreases the amount of acid produced by the stomach, along with two antibiotics: amoxicillin (a beta-lactam antibiotic) and clarithromycin (a macrolide antibiotic). The antibiotics work by killing bacteria or preventing their growth, while vonoprazan provides prolonged acid inhibition to create an environment where the antibiotics can work more effectively against H. pylori.
- Brand names
- Voquezna Triple PakVonosap
- Other names
- vonoprazan/amoxicillin/clarithromycinvonoprazan + amoxicillin + clarithromycin
02
Targets
Bacterial 50S ribosomal subunitPBP (Penicillin-binding protein family)ATP4A (Potassium–transporting ATPase alpha chain 1)
Beyond the preview
Go deeper on vonoprazan + amoxicillin + clarithromycin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vonoprazan + amoxicillin + clarithromycin.